FLARETX

Welcome to the Brand page for “FLARETX”, which is offered here for Custom manufacture of biochemical systems, custom manufacture of systems for targeting transcription factors; custom manufacturing for others, manufacturing of pharmaceutical preparations for the treatment of cancer, autoimmune diseases, and immunological disorders;house mark for chemical and biochemical preparations and substances for medical purposes for treatment and/or diagnosis of cancer, autoimmune diseases and immunological disorders; house mark for pharmaceutical preparations for targeting transcription factors; house mark for immunotherapy products, pharmaceutical preparations for the treatment of cancer, autoimmune diseases, and immunological disorders; house mark for biological preparations for the treatment of cancer, autoimmune diseases, and immunological disorders;providing a website featuring information about the treatment and/or diagnosis of cancer, autoimmune diseases and immunological disorders;bio-technology and scientific services, research, and development services relating to bio-technology and science, transcription factors; pharmaceutical research and development; biological and bio-technology analysis services; scientific and medical laboratory services; biochemistry research services, treating therapeutic targets through biochemical preparations;.

Its status is currently believed to be active. Its class is unavailable. “FLARETX” is believed to be currently owned by “Flare Therapeutics Inc.”